Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
Ibrahim, Sherehan, Lowe, Jamie R, Bramante, Carolyn T, Shah, Surbhi, Klatt, Nichole R, Sherwood, Nancy, Aronne, Louis, Puskarich, Michael, Tamariz, Leonardo, Palacio, Ana, Bomberg, Eric, Usher, Michael, King, Samantha, Benson, Brad, Vojta, Deneen, Tignanelli, Chris, Ingraham, Nicholas
Published in Frontiers in endocrinology (Lausanne) (22.07.2021)
Published in Frontiers in endocrinology (Lausanne) (22.07.2021)
Get full text
Journal Article
Solution processed CZTS solar cells using amine-thiol systems: understanding the dissolution process and device fabrication
Lowe, Jamie C, Wright, Lewis D, Eremin, Dmitry B, Burykina, Julia V, Martens, Jonathan, Plasser, Felix, Ananikov, Valentine P, Bowers, Jake W, Malkov, Andrei V
Published in Journal of materials chemistry. C, Materials for optical and electronic devices (14.08.2020)
Published in Journal of materials chemistry. C, Materials for optical and electronic devices (14.08.2020)
Get full text
Journal Article
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers
Bose, Nandita, Ottoson, Nadine R, Qiu, Xiaohong, Harrison, Ben, Lowe, Jamie R, Uhlik, Mark T, Rathmann, Blaine T, Kangas, Takashi O, Jordan, Lindsay R, Ertelt, Kathleen E, Jonas, Adria Bykowski, Walsh, Richard M, Chan, Anissa S H, Fulton, Ross B, Leonardo, Steven M, Fraser, Kathryn A, Gorden, Keith B, Matson, Mark A, Graff, Jeremy R, Huhn, Richard D
Published in The Journal of immunology (1950) (15.05.2019)
Published in The Journal of immunology (1950) (15.05.2019)
Get full text
Journal Article
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
Engel-Riedel, Walburga, Lowe, Jamie, Mattson, Paulette, Richard Trout, J, Huhn, Richard D, Gargano, Michele, Patchen, Myra L, Walsh, Richard, Trinh, My My, Dupuis, Mariève, Schneller, Folker
Published in Journal for immunotherapy of cancer (27.02.2018)
Published in Journal for immunotherapy of cancer (27.02.2018)
Get full text
Journal Article
A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer
Meyerhardt, Jeffrey A, Grady, Michele M, Lowe, Jamie N, Gargano, Michele A, Huhn, Richard D, Braun, Ada H
Published in Journal for immunotherapy of cancer (06.11.2014)
Published in Journal for immunotherapy of cancer (06.11.2014)
Get full text
Journal Article
Surgical management of the neuropathic bladder
Lowe, Jamie B, Furness, 3rd, Peter D, Barqawi, Albaha Z, Koyle, Martin A
Published in Seminars in pediatric surgery (01.05.2002)
Published in Seminars in pediatric surgery (01.05.2002)
Get full text
Journal Article
Abstract LB-129: Imprime PGG, a soluble yeast β-glucan PAMP, in combination with Pembrolizumab induces infiltration and activation of both innate and adaptive immune cells within tumor sites in melanoma and triple-negative breast cancer (TNBC) patients
Uhlik, Mark T., Harrison, Ben, Gorden, Keith, Leonardo, Steven, Walsh, Richard, Ertelt, Kathleen, Gargano, Michele, Chisamore, Michael, Lowe, Jamie, Osterwalder, Bruno, Bose, Nandita, Graff, Jeremy
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
A phase 3 open-label, randomized, multicenter study of imprime PGG in combination with cetuximab in patients with KRAS wild type metastatic colorectal cancer
Huhn, Richard Dale, Lowe, Jamie, Grady, Michele M, Taitt, Corina Candiani, Braun, Ada H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A phase 3 open-label, randomized, multicenter study of Imprime PGG in combination with cetuximab in patients with KRAS wild type metastatic colorectal cancer
Huhn, Richard Dale, Lowe, Jamie, Grady, Michele, Taitt, Corina Candiani, Gargano, Michele Anne, Braun, Ada H.
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Durability and characteristics of objective tumor responses with the innate immune cell modulator Imprime PGG in combination with standard of care frontline treatment for patients (Pts) with metastatic non-squamous NSCLC
Engel-Riedel, Walburga, Schneller, Folker, Wolf, Martin, Schuette, Wolfgang, Ma, Mable, Mattson, Paulette, Lowe, Jamie R., Braun, Ada H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract LB-A31: Imprime PGG (Imprime) plus pembrolizumab (PEM): a phase 2 immunotherapeutic combination in patients selected for an Imprime-specific biomarker
O'Day, Steven, Bose, Nandita, Uhlik, Mark, Prathikanti, Radha, Harrison, Ben, Leonardo, Steven, Huhn, Richard, Ottoson, Nadine, Qiu, Xiaohong, Walsh, Richard, Mattson, Paulette, Ma, Mable, Ertelt, Katie, Lowe, Jamie, Gargano, Michele A., Chisamore, Michael, Osterwalder, Bruno, Graff, Jeremy
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Abstract 3688: Imprime PGG, a novel innate immune therapeutic in phase 2 clinical development, induces mobilization of monocytes and focalized recruitment of innate immune cells to tumor sites
Leonardo, Steven, Ottosson, Nadine, Gorden, Keith, Kangas, Takashi, Qiu, Xiaohong, Fulton, Ross, Harrison, Benjamin, Jonas, Adria, Walsh, Richard, Ertelt, Katie, Lowe, Jamie, Huhn, Richard, Graff, Jeremy, Bose, Nandita, Uhlik, Mark T.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
A multicenter, open-label, phase II study of PGG beta-glucan and pembrolizumab in patients (pts) with advanced melanoma (MEL) following progression on treatment with checkpoint inhibitors (CPI) or triple negative breast cancer (TNBC) failing front-line chemotherapy for metastatic disease
Iglesias, Jose Luis, Prathikanti, Radha, Ma, Bo, Mattson, Paulette, Kedrowski, Deb, Lowe, Jamie, Bose, Nandita, Ertelt, Katie E., Ottoson, Nadine, Uhlik, Mark T., Graff, Jeremy, Huhn, Richard Dale, Chisamore, Michael Jon
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Effect of imprime PGG on innate immune-activating pharmacodynamic changes in a phase I clinical study in healthy human volunteers
Bose, Nandita, Ottoson, Nadine, Harrison, Ben, Lowe, Jamie R., Matson, Mark, Qiu, Xiaohong, Bykowski Jonas, Adria, Rathmann, Blaine, Kangas, Takashi, Wurst, Lindsay R., Chan, Anissa S.H., Fraser, Kathryn, Walsh, Richard, Ertelt, Katie E., Leonardo, Steven, Fulton, Ross, Gorden, Keith, Uhlik, Mark, Graff, Jeremy, Huhn, Richard Dale
Published in Journal of clinical oncology (01.03.2017)
Published in Journal of clinical oncology (01.03.2017)
Get full text
Journal Article
Safety of Imprime PGG, a novel innate immune cell modulator, in adults with stage IV non-small cell lung cancer: an integrated analysis of two randomized phase 2 studies
Schneller, Folker, Engel-Riedel, Walburga, Thomas, Michael, Kollmeier, Jens, Sadjadian, Parvis, Wolf, Martin, Schuette, Wolfgang, Taitt, Corina Candiani, Huhn, Richard Dale, Ma, Mable, Mattson, Paulette, Lowe, Jamie R., Braun, Ada H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Abstract A26: Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC)
Thomas, Michael, Sadjadian, Parvis, Kollmeier, Jens, Hao, Zhonglin, Patchen, Myra, Lowe, Jamie, Mattson, Paulette, Huhn, Richard D., Bose, Nandita, Antonysamy, Mary, Gargano, Michele, Gordon, Keith, Schneller, Folker
Published in Clinical cancer research (15.01.2014)
Published in Clinical cancer research (15.01.2014)
Get full text
Journal Article
Endogenous anti-β-glucan antibodies, a potential predictive biomarker for the efficacy of soluble yeast β-1,3/1,6 glucan (Imprime PGG®) immunotherapy in cancer patients (VAC3P.947)
Antonysamy, Mary, Bose, Nandita, Chan, Anissa, Ertelt, Katie, Gorden, Keith, Grossman, William, Huhn, Richard, Jonas, Adria, Leonardo, Steven, Lowe, Jamie, Mattson, Paulette, McMurray, Diane, Nelson, Mariana, Ottoson, Nadine, Patchen, Myra, Qiu, Xiaohong, Rathman, Blaine, Walsh, Richard, Wurst, Lindsay, Yokoyama, Yumi
Published in The Journal of immunology (1950) (01.05.2014)
Published in The Journal of immunology (1950) (01.05.2014)
Get full text
Journal Article
Endogenous anti-β-glucan antibodies as a potential predictive biomarker for clinical response to imprime PGG immunotherapy in non-small cell lung cancer (NSCLC) patients
Bose, Nandita, Antonysamy, Mary, Patchen, Myra Louise, Lowe, Jamie R., Mattson, Paulette, Gargano, Michele Anne, Gorden, Keith, Leonardo, Steven, Walsh, Richard, Qui, Xiaohong, Ottoson, Nadine, Ertelt, Katie E., Wurst, Lindsay R., McMurray, Diane, Chan, Anissa S.H., Jonas, Adria, Huhn, Richard Dale, Thomas, Michael, Sadjadian, Parvis, Schneller, Folker
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article